id: NEW:probation_supervision_restrictions_to_sud_medication_treatment_rate_oud
name: Probation Supervision Restrictions on Medication Access â†’ Medication Treatment Rate for OUD
from_node:
  node_id: NEW:probation_supervision_restrictions
  node_name: Probation Supervision Restrictions on Medication Access
to_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: Medication Treatment Rate for OUD
direction: negative
category: political
mechanism_pathway:
- 'Step 1: Probation departments establish regulations that prohibit or restrict client use of certain
  FDA-approved medications for OUD'
- 'Step 2: Probation officers lack training and guidance on medication-assisted treatment options'
- 'Step 3: Organizational barriers prevent referrals to appropriate medication-based treatment'
- 'Step 4: Probation clients with OUD cannot access evidence-based pharmacological treatment'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Jessica Reichert and Lily Gleicher 2019. "Probation clients' barriers to access and
    use of opioid use disorder medications." https://doi.org/10.1186/s40352-019-0089-6
  supporting_citations:
  - Additional citations require full-text access - abstract references prior evidence on medication effectiveness
    but does not cite specific studies
  doi: 10.1186/s40352-019-0089-6
  citation_verified: true
  needs_manual_review: true
  citation_issues:
  - Primary citation doesn't match verified citation from literature search
last_updated: '2025-12-06'
version: '2.0'
description: Probation departments create structural barriers to medication-assisted treatment for opioid
  use disorder through organizational regulations, lack of staff training, and negative attitudes toward
  medications, preventing clients from accessing FDA-approved treatments despite strong evidence of effectiveness.
quantitative_effects:
  sample_size: 26
spatial_variation:
  varies_by_geography: true
  variation_notes: Study focused on Illinois probation departments, noting variations in regulations set
    by organization or jurisdiction that prohibit client use of medications
moderators:
- name: medication_type
  direction: strengthens
  strength: moderate
  description: Probation department leaders were less open to methadone referrals compared to buprenorphine
    or naltrexone, suggesting differential barriers by medication type
- name: staff_training_level
  direction: weakens
  strength: moderate
  description: Lack of medical personnel experience and need for guidance on medications increases barriers;
    training could reduce them
structural_competency:
  equity_implications: This mechanism highlights how criminal justice system policies and practices create
    health inequities for justice-involved populations. The barriers are structural (organizational regulations,
    lack of institutional training, cost) rather than individual failings. Probation clients face differential
    access to evidence-based healthcare due to their criminal justice status, representing a form of structural
    discrimination that affects a disproportionately low-income and minority population.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.213115'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
